It has been demonstrated in long-term studies that the majority of pregnant women who develop gestational diabetes have elevated IR brought on by changes in theinsulin signaling pathway, abnormal subcellular localization of GLUT4 transporters, increased expression of the membrane glycoprotein PC-1, or diminished insulin-mediated glucose transport [21]. The gene discussed is INS; the disease is gestational diabetes.